FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma

Respirology

Volumn 18, Issue 4, 2013, Pages 734-735

  Putora, Paul M ^a   Früh, Martin ^b   Müller, Joachim ^b  

^a Kantonsspital St Gallen   (Switzerland)

^b NONE   (Switzerland)

Author keywords

epidermal growth factor receptor; genetic association; imaging; lung cancer; primary tumour standardized uptake

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE;

ARTICLE; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; MAXIMUM STANDARDIZED UPTAKE VALUE; POINT MUTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS;

ADENOCARCINOMA; CASE-CONTROL STUDIES; CELL PROLIFERATION; FLUORODEOXYGLUCOSE F18; GENOTYPE; HUMANS; LUNG NEOPLASMS; MUTATION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE;

EID: 84876888471     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12083     Document Type: Article

References (6)

1. Förster GJ, Misch D, Kollmeier J, et al. Der SUV im FDG-PET als prädiktiver Wert einer EGFR-Mutation beim nicht-kleinzelligen Lungenkarzinom. Pneumologie 2012; 66: P201.
2. Na II, Byun BH, Kim KM, et al. 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: a single-institution retrospective analysis. Lung Cancer 2010; 67: 6-80.
3. Huang CT, Yen RF, Cheng MF, et al. Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma. Med. Oncol. 2010; 27: 9-15.
4. Mak RH, Digumarthy SR, Muzikansky A, et al. Role of 18F- fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer. Oncologist 2011; 16: 19-26.
5. Vansteenkiste J, Fischer BM, Dooms C, et al. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol. 2004; 5: 31-40.
6. Dhital K, Saunders CA, Seed PT, et al. [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur. J. Cardiothorac. Surg. 2000; 18: 25-28.